Yu, S., Yu, M., Keane, B., Mauro, D. M., Helft, P. R., Harris, W. P., . . . Somasundaram, A. (2024). A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma. The oncologist (Dayton, Ohio), 29(3), 270-e413. https://doi.org/10.1093/oncolo/oyad331
Citace podle Chicago (17th ed.)Yu, Shawn, et al. "A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma." The Oncologist (Dayton, Ohio) 29, no. 3 (2024): 270-e413. https://doi.org/10.1093/oncolo/oyad331.
Citace podle MLA (9th ed.)Yu, Shawn, et al. "A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma." The Oncologist (Dayton, Ohio), vol. 29, no. 3, 2024, pp. 270-e413, https://doi.org/10.1093/oncolo/oyad331.